INS and metabolic dysfunction-associated steatohepatitis: More pathways were specifically dysregulated in NASH-HCCs, including those previously reported in NAFLD (calcium, insulin, hedgehog and adipocytokine signaling11,12), and cancer (axon guidance and cell adhesion).